1227162-47-1

Basic information

• Product Name: (S)-5-amino-(2-benzyloxycarbonylamino)-5-oxo-(2,3,3,4,4-d5)-pentanoic acid
• Synonyms: (S)-5-amino-(2-benzyloxycarbonylamino)-5-oxo-(2,3,3,4,4-d5)-pentanoic acid
• CAS NO: 1227162-47-1
• Molecular Weight: 285.241
• Mol File: 1227162-47-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (S)-5-amino-(2-benzyloxycarbonylamino)-5-oxo-(2,3,3,4,4-d5)-pentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-5-amino-(2-benzyloxycarbonylamino)-5-oxo-(2,3,3,4,4-d5)-pentanoic acid(1227162-47-1)
• EPA Substance Registry System: (S)-5-amino-(2-benzyloxycarbonylamino)-5-oxo-(2,3,3,4,4-d5)-pentanoic acid(1227162-47-1)

Safety Data

• Hazardous Substances Data: 1227162-47-1(Hazardous Substances Data)

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 14341-78-7 L-glutamine-2,3,3,4,4-d5 

Downstream Products

• 1227162-48-2 (S)-benzyl 2,6-dioxo(piperidin-3,4,4,5,5-d5)-3-ylcarbamate 
• 1381794-67-7 C₁₃H₇⁽²⁾H₇N₂O₄ 

Relevant articles and documents

SUBSTITUTED DIOXOPIPERIDINYL PHTHALIMIDE DERIVATIVES

This invention relates to novel substituted dioxopiperidinyl phthalimide derivatives and pharmaceutically acceptable acid addition salts thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by an immunomodulatory agent.

SUBSTITUTED DIOXOPIPERIDINYL PHTHALIMIDE DERIVATIVES

This invention relates to novel substituted dioxopiperidinyl phthalimide derivatives of formula (I) or a pharmaceutically acceptable salt thereof, wherein: each W is independently selected from hydrogen or deuterium; each Z is independently selected from

SUBSTITUTED DIOXOPIPERIDINYL PHTHALIMIDE DERIVATIES

This invention relates to novel substituted dioxopiperidinyl phthalimide derivatives and pharmaceutically acceptable acid addition salts thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by an immunomodulatory agent.